H.R. 501 · 118th Congress (2023–2025)
Block, Report, and Suspend Suspicious Shipments Act
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order or series of suspicious orders for controlled substances.
Currently, a manufacturer or distributor must report a suspicious order or series of suspicious orders to the Drug Enforcement Administration (DEA). This bill also requires a manufacturer or distributor to exercise due diligence and decline to fill the order. However, if the manufacturer or distributor resolves all of the indicators giving rise to the suspicious order or series of suspicious orders, then the bill allows the manufacturer or distributor to fill the order and choose not to report it to the DEA.
A violation is subject to civil and criminal penalties under the Controlled Substances Act.
The DEA must issue regulations specifying the indicators that give rise to a suspicious order.
Show official title
To amend the Controlled Substances Act to require registrants to decline to fill certain suspicious orders, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReported by committee
This bill’s path
This is H.R. 501’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Diana Harshbarger (R-TN-1)
- Cosponsors
7 cosponsors
1 original · 6 later
3 R · 4 D
- Rep. Debbie Dingell (D-MI-6)· Original · Jan 25, 2023
- Rep. Ashley Hinson (R-IA-2)· Later · Jan 31, 2023
- Rep. Susie Lee (D-NV-3)· Later · Feb 2, 2023
- Rep. Jill N. Tokuda (D-HI-2)· Later · Feb 14, 2023
- Rep. Juan Ciscomani (R-AZ-6)· Later · Feb 28, 2023
- Rep. Kim Schrier (D-WA-8)· Later · Mar 14, 2023
- Rep. Marcus J. Molinaro (R-NY-19)· Later · Apr 3, 2023
- Policy area
- Crime and Law Enforcement
- Subjects
- Administrative law and regulatory procedures
- Department of Justice
- Drug trafficking and controlled substances
- Prescription drugs
- Retail and wholesale trades
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 8 committee actions · Jan 25, 2023 – May 17, 2023
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Subcommittee markup session held
Subcommittee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Forwarded by subcommittee
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 28 - 0 .
Sources
- Congress.gov action
- House committee actions
Markup session held
Committee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Markup session held
Committee Consideration and Mark-up Session Held.
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Sources
- Congress.gov action
- House committee actions
Committee discharged
Committee on the Judiciary discharged.
Sources
- Congress.gov action
- House floor actions
Reported by committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-66, Part I.
Sources
- Congress.gov action
- House floor actions
Expired
Introduced → Reported by committee → No further action before the 118th Congress ended.
Committees
- HouseEnergy and CommerceReferred Jan 25, 2023 · Markup Mar 23, 2023 · Markup Mar 24, 2023 · Reported May 17, 2023H. Rept. 118-66
Mar 23, 2023 · Markup
Mar 8, 2023 · Meeting
Feb 1, 2023 · Hearing
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
Titles (3)
Block, Report, and Suspend Suspicious Shipments Act
Display title, Short title · Reported in House
Block, Report, And Suspend Suspicious Shipments Act
Short title · Introduced in House
To amend the Controlled Substances Act to require registrants to decline to fill certain suspicious orders, and for other purposes.
Official title · Introduced in House